Ping An Biomedical Announces Planned Acquisition of Medical Technology Patents

Ping An Biomedical Co., Ltd. (NASDAQ: PASW) has signed a letter of intent to acquire three tumor cell-related medical technology patents from Future Biotechnology Group Co., Limited, valued between US$2 million and US$2.5 million. This acquisition aims to enhance its healthcare and biomedical strategy by building a core intellectual property portfolio in oncology diagnosis, treatment, and bioengineering. The company anticipates that this intellectual property reserve will facilitate future internal development, licensing, and commercialization of healthcare technology assets.